Adhera Therapeutics, Inc. | Note Agreements | Business Contracts

Form of Original Issue Discount Senior Secured Promissory Note (Filed With SEC on March 8, 2023)

Form of Original Issue Discount Senior Secured Promissory Note (Filed With SEC on February 23, 2023)

Form of Original Issue Discount Senior Secured Promissory Note (Filed With SEC on January 26, 2023)

Form of Senior Secured Original Issue Discount Promissory Note dated May 11, 2022 (Filed With SEC on May 16, 2022)

Form of Convertible Redeemable Promissory Note issued by Adhera Therapeutics, Inc. to select accredited investors on March 15, 2022 (Filed With SEC on April 15, 2022)

Form of 10% Convertible Redeemable Note (Filed With SEC on November 12, 2021)

Form of 10% Convertible Redeemable Note (Filed With SEC on October 13, 2021)

Form of Convertible Promissory Note (Filed With SEC on August 24, 2021)

Form of Convertible Promissory Note issued by Adhera Therapeutics, Inc. to select accredited investors on June 25, 2021 (Filed With SEC on August 23, 2021)

Form of Convertible Promissory Note (Filed With SEC on August 18, 2021)

Form of Convertible Promissory Note (Filed With SEC on April 23, 2021)

Form of Convertible Promissory Note (Filed With SEC on February 9, 2021)

Form of Senior Secured Convertible Note (Filed With SEC on November 5, 2020)

Form of Convertible Promissory Note (Filed With SEC on June 30, 2020)

Form of Convertible Promissory Note (Filed With SEC on February 11, 2020)

Security Agreement, dated as of June 28, 2019, among Adhera Therapeutics, Inc., IThenaPharma, Inc., Cequent Pharmaceuticals, Inc., MDRNA Research, Inc., the purchasers of secured... (Filed With SEC on July 3, 2019)

Form of Secured Promissory Note (Filed With SEC on July 3, 2019)

Adhera Therapeutics, Inc. (57) | Note Agreements (17)